Impact of High-dose Vitamin D on Plasma Free 25-hydroxyvitamin D Concentrations and Antimicrobial Peptides in Critically Ill Mechanically Ventilated Adults

Overview

Journal Nutrition

Specialty Nutritional Sciences

Date 2017 May 21

PMID 28526374

Citations 18

Authors

Jenny E Han

Jessica A Alvarez

Jennifer L Jones

Vin Tangpricha

Mona A Brown

Li Hao

Lou Ann S Brown

Greg S Martin

Thomas R Ziegler

Affiliations

Soon will be listed here.

Abstract

Objectives: High-dose vitamin D increases plasma total 25-hydroxyvitamin D [25(OH)D] in critically ill, ventilated patients; however, to our knowledge, the effect on plasma levels of free (nonprotein-bound) 25(OH)D has not been investigated in critical illness. Moreover, the relationship of free 25(OH)D and the regulation of endogenous antimicrobial peptides (AMPs) remains unknown. The aims of this study were to determine in critically ill adults with respiratory failure the effect of previous high-dose regimens of vitamin D on free 25(OH)D concentrations, the relationship of free 25(OH)D with circulating cathelicidin (LL-37) and human beta-defensin-2 (hBD-2), and the associations between plasma levels of free 25(OH)D and these AMPs to alveolar macrophage phagocytosis function.

Methods: In a double blind, randomized controlled trial, critically ill ventilator-dependent adults (N = 30) received enteral vitamin D (250,000 or 500,000 IU total over 5 d) or placebo. Plasma was obtained serially for concentrations of free 25(OH)D, LL-37, hBD-2, and expression of peripheral blood mononuclear cell human cationic antimicrobial protein (hCAP18) mRNA. Total 25(OH)D and LL-37 concentrations and alveolar macrophage phagocytosis were determined in bronchoalveolar lavage fluid.

Results: Plasma concentrations of free 25(OH)D over time were correlated with total 25(OH)D levels (r= 0.82; P < 0.001). The increase in free 25(OH)D was greater with the 500 000 IU vitamin D dose than with the lower dose. The percent change in mRNA expression of hCAP18 was positively associated with percent change in free 25(OH)D at days 7 and 14 (ρ = 0.48; P = 0.04 and ρ = 0.59; P = 0.03, respectively). Additionally, plasma LL-37 levels correlated with the percentage of alveolar macrophages exhibiting phagocytosis (ρ = 0.51; P = 0.04).

Conclusions: The present study found a dose-related increase in plasma free-25(OH)D levels, which was associated with increasing circulating mRNA expression of hCAP18 over time. There were no correlations between changes in total and free 25(OH)D against plasma LL-37 and hBD-2 concentrations. Larger studies appear warranted to determine the impact of high-dose vitamin D administration on endogenous AMPs.

Citing Articles

Vitamin D Supplementation in Critically Ill-Narrative Review.

Saric L, Domazet Bugarin J, Dosenovic S Nutrients. 2025; 17(1.

PMID: 39796590 PMC: 11723408. DOI: 10.3390/nu17010156.

Systemic Factors Affecting Human Beta-Defensins in Oral Cavity.

Atalay N, Balci N, Gursoy M, Gursoy U Pathogens. 2024; 13(8).

PMID: 39204254 PMC: 11357671. DOI: 10.3390/pathogens13080654.

Free and bioavailable 25-hydroxyvitamin D thresholds for bone metabolism and their associations with metabolic syndrome in Chinese women of childbearing age.

Shan X, Cao Y, Zhang H, Zhao X, Li S, Hu Y Front Nutr. 2023; 10:1131140.

PMID: 37736136 PMC: 10509557. DOI: 10.3389/fnut.2023.1131140.

Expression, purification and investigation of antibacterial activity of a novel hybrid peptide LL37/hBD-129 by applied comprehensive computational and experimental approaches.

Abbasi M, Behmard E, Yousefi M, Shekarforoush S, Mahmoodi S Arch Microbiol. 2023; 205(5):199.

PMID: 37069440 DOI: 10.1007/s00203-023-03529-5.

Does Vitamin D Improve All-cause Mortality in Critically Ill Adults? An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials.

Kaur M, Soni K, Trikha A Indian J Crit Care Med. 2023; 26(7):853-862.

PMID: 36864868 PMC: 9973187. DOI: 10.5005/jp-journals-10071-24260.

References

Lee P, Eisman J, Center J . Vitamin D deficiency in critically ill patients. N Engl J Med. 2009; 360(18):1912-4. DOI: 10.1056/NEJMc0809996. View

Tangpricha V, Kelly A, Stephenson A, Maguiness K, Enders J, Robinson K . An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab. 2012; 97(4):1082-93. DOI: 10.1210/jc.2011-3050. View

Ala-Kokko T, Mutt S, Nisula S, Koskenkari J, Liisanantti J, Ohtonen P . Vitamin D deficiency at admission is not associated with 90-day mortality in patients with severe sepsis or septic shock: Observational FINNAKI cohort study. Ann Med. 2016; 48(1-2):67-75. DOI: 10.3109/07853890.2015.1134807. View

Yang Y, Guo Y, Zhang H, Sun T . Antimicrobial peptide LL-37 circulating levels in chronic obstructive pulmonary disease patients with high risk of frequent exacerbations. J Thorac Dis. 2015; 7(4):740-5. PMC: 4419288. DOI: 10.3978/j.issn.2072-1439.2015.04.33. View

De Pascale G, Vallecoccia M, Schiattarella A, Di Gravio V, Cutuli S, Bello G . Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care. Clin Microbiol Infect. 2016; 22(5):456.e7-456.e13. DOI: 10.1016/j.cmi.2015.12.015. View

Book M, Chen Q, Lehmann L, Klaschik S, Weber S, Schewe J . Inducibility of the endogenous antibiotic peptide beta-defensin 2 is impaired in patients with severe sepsis. Crit Care. 2007; 11(1):R19. PMC: 2151902. DOI: 10.1186/cc5694. View

Gombart A . The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 2009; 4(9):1151-65. PMC: 2821804. DOI: 10.2217/fmb.09.87. View

Wan M, van der Does A, Tang X, Lindbom L, Agerberth B, Haeggstrom J . Antimicrobial peptide LL-37 promotes bacterial phagocytosis by human macrophages. J Leukoc Biol. 2014; 95(6):971-81. DOI: 10.1189/jlb.0513304. View

Beaumont P, McHugh B, Gwyer Findlay E, Mackellar A, Mackenzie K, Gallo R . Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo. PLoS One. 2014; 9(6):e99029. PMC: 4041793. DOI: 10.1371/journal.pone.0099029. View

10.

Kempker J, West K, Kempker R, Siwamogsatham O, Alvarez J, Tangpricha V . Vitamin D status and the risk for hospital-acquired infections in critically ill adults: a prospective cohort study. PLoS One. 2015; 10(4):e0122136. PMC: 4388655. DOI: 10.1371/journal.pone.0122136. View

11.

Liu P, Stenger S, Li H, Wenzel L, Tan B, Krutzik S . Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006; 311(5768):1770-3. DOI: 10.1126/science.1123933. View

12.

Higgins D, Wischmeyer P, Queensland K, Sillau S, Sufit A, Heyland D . Relationship of vitamin D deficiency to clinical outcomes in critically ill patients. JPEN J Parenter Enteral Nutr. 2012; 36(6):713-20. DOI: 10.1177/0148607112444449. View

13.

Braun A, Gibbons F, Litonjua A, Giovannucci E, Christopher K . Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med. 2011; 40(1):63-72. PMC: 4427350. DOI: 10.1097/CCM.0b013e31822d74f3. View

14.

Barlow P, Svoboda P, Mackellar A, Nash A, York I, Pohl J . Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One. 2011; 6(10):e25333. PMC: 3198734. DOI: 10.1371/journal.pone.0025333. View

15.

Ziegler T . Parenteral nutrition in the critically ill patient. N Engl J Med. 2009; 361(11):1088-97. PMC: 3064749. DOI: 10.1056/NEJMct0806956. View

16.

Leaf D, Raed A, Donnino M, Ginde A, Waikar S . Randomized controlled trial of calcitriol in severe sepsis. Am J Respir Crit Care Med. 2014; 190(5):533-41. PMC: 4214090. DOI: 10.1164/rccm.201405-0988OC. View

17.

Nair P, Lee P, Reynolds C, Nguyen N, Myburgh J, Eisman J . Significant perturbation of vitamin D-parathyroid-calcium axis and adverse clinical outcomes in critically ill patients. Intensive Care Med. 2012; 39(2):267-74. DOI: 10.1007/s00134-012-2713-y. View

18.

Hebbar K, Wittkamp M, Alvarez J, McCracken C, Tangpricha V . Vitamin D Deficiency in Pediatric Critical Illness. J Clin Transl Endocrinol. 2015; 1(4):170-175. PMC: 4286794. DOI: 10.1016/j.jcte.2014.09.002. View

19.

Weber G, Heilborn J, Chamorro Jimenez C, Hammarsjo A, Torma H, Stahle M . Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol. 2005; 124(5):1080-2. DOI: 10.1111/j.0022-202X.2005.23687.x. View

20.

Brown L, Perez J, HARRIS F, Clark R . Glutathione supplements protect preterm rabbits from oxidative lung injury. Am J Physiol. 1996; 270(3 Pt 1):L446-51. DOI: 10.1152/ajplung.1996.270.3.L446. View